Error: Could not add to watchlist. X

InSite Vision Inc

+ Watchlist
IVF:GR
Ticker Delisted
EUR
Volume
0
Current P/E Ratio (TTM)
-
Earnings per Share (USD) (TTM)
-
Market Cap (EUR)
-
Shares Outstanding
-
Price/Sales (TTM)
-
Dividend Indicated Gross Yield
-
Sector
Health Care
Industry
Biotech & Pharma
Sub-Industry
Specialty Pharma

Related Videos

There are currently no related videos for this ticker. Please check back later.
There are currently no news stories for this ticker. Please check back later.
There are currently no press releases for this ticker. Please check back later.
Profile
InSite Vision Incorporated develops ophthalmic pharmaceutical products based on its DuraSite drug delivery technology. The Company also develops genetically based tools for the diagnosis and prognosis of glaucoma. InSite's products are intended to address a broad spectrum of ocular indications, including glaucoma, inflammation, and infection.
ADDRESS
965 Atlantic Avenue
Alameda, CA 94501
United States
PHONE
1-510-865-8800
  • Timothy M Ruane
    Chief Executive Officer
  • Louis C Drapeau
    VP/CFO
  • Kamran Hosseini
    VP:Clinical & Regulatory
  • Lyle M Bowman
    VP:Development/Secretary
  • Surendra Patel
    VP:Operations & Quality
Show More